500420 logo

Torrent Pharmaceuticals Limited Stock Price

BSE:500420 Community·₹1.2t Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

500420 Share Price Performance

₹3,513.95
38.35 (1.10%)
10.6% undervalued intrinsic discount
₹3,929.42
Fair Value
₹3,513.95
38.35 (1.10%)
10.6% undervalued intrinsic discount
₹3,929.42
Fair Value
Price ₹3,513.95
AnalystConsensusTarget ₹3,929.42

500420 Community Narratives

AnalystConsensusTarget·Updated
Fair Value ₹3.93k 10.6% undervalued intrinsic discount

Robust Indian And Brazilian Markets Will Unlock Potential

1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Recent 500420 News & Updates

Torrent Pharmaceuticals Limited Key Details

₹118.4b

Revenue

₹28.6b

Cost of Revenue

₹89.8b

Gross Profit

₹69.8b

Other Expenses

₹20.0b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
59.16
Gross Margin
75.87%
Net Profit Margin
16.92%
Debt/Equity Ratio
42.8%

Torrent Pharmaceuticals Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

1 Risk
2 Rewards

About 500420

Founded
1959
Employees
17059
CEO
Aman Mehta
WebsiteView website
www.torrentpharma.com

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. Longer term the market is actually down 4.7% over the past year. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›